Nutrition and Physical Activity Assessment Study - Assessment of Dietary Supplements
营养和身体活动评估研究 - 膳食补充剂的评估
基本信息
- 批准号:10271554
- 负责人:
- 金额:$ 17.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-08 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdministrative SupplementAffectBeta CaroteneBiological MarkersBloodCategoriesChronic DiseaseClassificationCollectionConsumptionDataDietDietary AssessmentDietary PracticesDoseEatingFastingFolic AcidFoodFood PatternsFood SupplementsFundingGoalsIntakeLuteinMass FragmentographyMeasuresModelingNutrientNutritionalObservational StudyParticipantPhysical activityProtocols documentationRecordsReportingResearchSerumSpottingsTextUrineValidationVariantWomanWomen&aposs HealthWorkalpha Tocopherolalpha-carotenebiomarker discoverydietarydietary supplementsdisorder riskdoubly-labeled waterfeedinggamma-Tocopherolimprovedlycopenemetabolomicsnovelnutritionnutritional epidemiologyparent grantpreservationresponsestudy populationzeaxanthin
项目摘要
ABSTRACT
We are responding to PA-20-227 “Administrative Supplement for Research on Dietary Supplements” to
support dietary supplement-related analysis of previously collected data on our parent grant R01 CA119171,
“Nutrition and Physical Activity Assessment Study,” (NPAAS). The goal of the NPAAS parent grant is to
discover and utilize novel, reliable biomarkers of nutrients, foods and dietary patterns to enhance the field of
nutritional epidemiology and the understanding diet-related chronic disease risk. In previous funding cycles we
implemented dietary assessment, doubly labeled water (DLW) and biospecimen collection protocols (2006-
2010) in 450 participants in the Women’s Health Initiative (WHI) Observational Study (NPAAS-OS). We next
conducted a novel controlled feeding study in 153 WHI participants (2011-2014), in which each participant was
provided a diet approximating her usual diet so that blood and urine measures would stabilize quickly and
intake variations in the study population would be preserved, and we implemented the DLW and biospecimen
collection protocols in NPAAS-FS to match NPAAS-OS. In both studies, fasting blood and urine (24-h and
spot) were analyzed for nutrients (B-12, folate, alpha- & beta-carotene, lutein + zeaxanthin, lycopene, alpha-
and gamma tocopherol) and metabolomics by 3 platforms: GC-MS, LC-MS and NMR. Dietary supplement
intake data were also collected; 68% of women in the NPAAS-OS and 88% in the NPAAS-FS reported using
supplements. The work proposed for this Administrative Supplement will make use of these previously
collected data. The Supplement specific aims are: ) To create constructed variables from the open-ended text
field dietary supplement records in the NPAAS-FS multiple day food records; 2) To describe common
categories of dietary supplement exposure in NPAAS participants using the new constructed variables from
NPAAS-FS and NPAAS-OS; 3) To characterize the contribution of specific categories of dietary supplement
use to the overall associations between consumed nutrients and dietary biomarkers in NPAAS-FS and to apply
the models in NPAAS-OS; and 4) To evaluate the utility of combinations of established nutrient biomarkers and
serum and urine metabolomics profiles to characterize nutrient intakes from food and dietary supplements in
the NPAAS-FS and NPAAS-OS. To date, the dietary supplement data for NPAAS-FS and NPAAS-OS have
not been fully categorized. Further classification of the supplement data into useable categories (single
supplements, multi-ingredients, other combinations) may be important because our initial work in the NPAAS-
FS showed that a binary (yes/no) dietary supplement use variable was an important predictor in analyses of
the association between concentration biomarkers and nutrient intake. Use of only a binary variable for such a
purpose is very limiting. In response, this Administrative Supplement will lead to estimates of total nutrient
exposure from food + supplements thereby enhancing nutritional biomarker discovery, validation and
application. These goals align well with the parent grant’s aims.
抽象的
我们对PA-20-227的回应是“对饮食中的研究的行政补充”
支持先前收集的数据我们父母赠款R01 CA119171的与饮食补充相关的分析,
“营养和体育活动评估研究”。
发现并利用营养,食物和饮食模式的新颖,可靠的生物标志物,以增强领域
营养流行病学和与饮食相关的慢性疾病的理解。
实施饮食评估,双标记水(DLW)和Biospecimen收集方案(2006--
2010年)在妇女健康计划(WHI)观察性研究(NPAAS-OS)中
在153名参与者(2011- 2014年)中进行了一项新颖的受控喂养研究,其中每个参与者都是
提供了近似她通常饮食的饮食
研究人群中的摄入量变化将被保留
NPAAS-F中的收集方案匹配NPAAS-OS。
分析斑点的养分(B-12,叶酸,α-和β-胡萝卜素,叶黄素 + Zeaxanthin,lycopha--
3个平台通过3个平台:GC-MS,LC-MS和NMR。
还收集了68%的进气数据
补品。
收集数据。
NPAAS-FS多天食品记录中的现场饮食补充记录;
NPAA参与者的饮食支持类别,使用了新的构造变量
NPAAS-FS和NPAAS-OS
用于NPAAS-FS中消耗的营养和饮食生物标志物之间的整体关联并应用
NPAAS-OS中的模型
血清和尿液代谢组学以养分为特征的食物和饮食供应中的营养素
NPAAS-FS和NPAAS-OS。
没有完全分类。
补品,多层,其他组合)可能很重要,因为我们的Kause在NPAAS-中起作用
FS表明二进制(是/否)饮食补充剂使用变量是分析的重要预测
浓度生物标志物与营养摄入量之间的关联。
目的是非常有限的。
食物 +补充剂的接触,从而增强营养生物标志物的发现,验证和
这些目标与父母赠款的AMS保持一致。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHANNA W LAMPE其他文献
JOHANNA W LAMPE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHANNA W LAMPE', 18)}}的其他基金
Human and Bacterial Molecular Pathways in Cancer Risk: Modulation by Diet
人类和细菌癌症风险的分子途径:饮食调节
- 批准号:
9187871 - 财政年份:2015
- 资助金额:
$ 17.56万 - 项目类别:
Characterizing Novel Estrogen Biomarkers Implicated in Breast Cancer Initiation
表征与乳腺癌发生有关的新型雌激素生物标志物
- 批准号:
8601152 - 财政年份:2013
- 资助金额:
$ 17.56万 - 项目类别:
Characterizing Novel Estrogen Biomarkers Implicated in Breast Cancer Initiation
表征与乳腺癌发生有关的新型雌激素生物标志物
- 批准号:
8445138 - 财政年份:2013
- 资助金额:
$ 17.56万 - 项目类别:
Flaxseed effects on hormones and lignans: role of race, genes, and gut microbiome
亚麻籽对激素和木脂素的影响:种族、基因和肠道微生物组的作用
- 批准号:
8550782 - 财政年份:2012
- 资助金额:
$ 17.56万 - 项目类别:
Flaxseed effects on hormones and lignans: role of race, genes, and gut microbiome
亚麻籽对激素和木脂素的影响:种族、基因和肠道微生物组的作用
- 批准号:
8918500 - 财政年份:2012
- 资助金额:
$ 17.56万 - 项目类别:
Flaxseed effects on hormones and lignans: role of race, genes, and gut microbiome
亚麻籽对激素和木脂素的影响:种族、基因和肠道微生物组的作用
- 批准号:
8728786 - 财政年份:2012
- 资助金额:
$ 17.56万 - 项目类别:
Flaxseed effects on hormones and lignans: role of race, genes, and gut microbiome
亚麻籽对激素和木脂素的影响:种族、基因和肠道微生物组的作用
- 批准号:
8372722 - 财政年份:2012
- 资助金额:
$ 17.56万 - 项目类别:
Associations of Gut Microbiome Predictors of Body Fat Amount and Distribution
肠道微生物组与体脂肪量和分布的预测因子之间的关联
- 批准号:
8374230 - 财政年份:2012
- 资助金额:
$ 17.56万 - 项目类别:
Cruciferous vegetable feeding and inflammation: effect of GST genotypes
十字花科蔬菜取食与炎症:GST 基因型的影响
- 批准号:
7983138 - 财政年份:2010
- 资助金额:
$ 17.56万 - 项目类别:
Cruciferous vegetable feeding and inflammation: effect of GST genotypes
十字花科蔬菜取食与炎症:GST 基因型的影响
- 批准号:
8081780 - 财政年份:2010
- 资助金额:
$ 17.56万 - 项目类别:
相似海外基金
Programs for the Training and Advancement of the Next GENeration of Native Researchers in Genetics, Ethics and Society
下一代本土遗传学、伦理学和社会研究人员的培训和提升计划
- 批准号:
10841760 - 财政年份:2023
- 资助金额:
$ 17.56万 - 项目类别:
Improving identification and healthcare for patients with Inherited Cancer Syndromes: Evidence-based EMR implementation using a web-based computer platform
改善遗传性癌症综合征患者的识别和医疗保健:使用基于网络的计算机平台实施基于证据的 EMR
- 批准号:
10831647 - 财政年份:2023
- 资助金额:
$ 17.56万 - 项目类别:
Identifying how alcohol-evoked changes in neural firing affect systems level computations during decision-making
确定酒精引起的神经放电变化如何影响决策过程中的系统级计算
- 批准号:
10766877 - 财政年份:2023
- 资助金额:
$ 17.56万 - 项目类别:
Bioethical Issues Associated with Objective Behavioral Measurement of Children with Hearing Loss in Naturalistic Environments
与自然环境中听力损失儿童的客观行为测量相关的生物伦理问题
- 批准号:
10790269 - 财政年份:2023
- 资助金额:
$ 17.56万 - 项目类别:
South Carolina Clinical & Translational Research Institute (SCTR)
南卡罗来纳州临床
- 批准号:
10820346 - 财政年份:2023
- 资助金额:
$ 17.56万 - 项目类别: